Ryan Preblick
Finanzdirektor/CFO bei INDIVIOR PLC
Vermögen: 1 Mio $ am 30.04.2024
Aktive Positionen von Ryan Preblick
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
INDIVIOR PLC | Finanzdirektor/CFO | 29.06.2020 | - |
Direktor/Vorstandsmitglied | 20.11.2020 | - | |
Comptroller/Controller/Auditor | 01.01.2012 | 01.01.2020 | |
Corporate Officer/Principal | 01.01.2020 | 29.06.2020 | |
OPIANT PHARMACEUTICALS, INC. | Finanzdirektor/CFO | - | - |
Unternehmenssekretär | - | - | |
Treasurer | - | - |
Karriereverlauf von Ryan Preblick
Ausbildung von Ryan Preblick
The Pennsylvania State University | Undergraduate Degree |
University of Richmond | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Director of Finance/CFO | 2 |
Comptroller/Controller/Auditor | 1 |
Director/Board Member | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
INDIVIOR PLC | Health Technology |
Private Unternehmen | 1 |
---|---|
Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
- Börse
- Insiders
- Ryan Preblick
- Erfahrung